Molecular characteristics of autoimmune pancreatitis

Current Pharmaceutical Design

Volumn 12, Issue 29, 2006, Pages 3781-3786

  Jaster, Robert ^a   Emmrich, Jörg ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Autoimmune pancreatitis; Molecular pathogenesis

Indexed keywords

PREDNISOLONE; STEROID;

AUTOIMMUNE DISEASE; AUTOIMMUNE PANCREATITIS; COMORBIDITY; DRUG RESPONSE; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOLOGY; MAINTENANCE DRUG DOSE; NONHUMAN; PANCREATITIS; PATHOGENESIS; PRIORITY JOURNAL; RETROPERITONEAL FIBROSIS; REVIEW; SCLEROSING CHOLANGITIS; SJOEGREN SYNDROME; STEROID THERAPY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; GLUCOCORTICOIDS; HUMANS; PANCREAS; PANCREATITIS, CHRONIC; PREDNISOLONE;

EID: 33749863258     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161206778559812     Document Type: Review

References (54)

1. Steer ML, Waxman I, Freedman S. Pancreatic lesions associated with chronic ulcerative colitis. N Engl J Med 1995; 332(22): 1482-90.
2. Ball WP, Baggenstoss AH, Bargen JA. Chronic pancreatitis. Arch Pathol (Chic) 1950; 50(3): 347-58.
3. Thal AP, Murray MJ, Egner W. Isoantibody formation in chronic pancreatic disease. Lancet 1959; 1(7083): 1128-9.
4. Sarles H, Sarles JC, Camatte R, Muratore R, Gaini M, Guien C, et al. Observations on 205 confirmed cases of acute pancreatitis, recurring pancreatitis, and chronic pancreatitis. Gut 1965; 6(6): 545-59.
5. Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995; 40(7): 1561-8.
6. Kloppel G, Luttges J, Lohr M, Zamboni G, Longnecker D. Autoimmune pancreatitis: pathological, clinical, and immunological features. Pancreas 2003; 27(1): 14-9.
7. Okazaki K, Uchida K, Chiba T. Recent concept of autoimmune-related pancreatitis. J Gastroenterol 2001; 36(5): 293-302.
8. Davidson TS, Longnecker DS, Hickey WF. An experimental model of autoimmune pancreatitis in the rat. Am J Pathol 2005; 166(3): 729-36.
9. Pearson RK, Longnecker DS, Chari ST, Smyrk TC, Okazaki K, Frulloni L, et al. Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist? Pancreas 2003; 27(1): 1-13.
10. Howes N, Greenhalf W, Stocken DD, Neoptolemos JP. Cationic trypsinogen mutations and pancreatitis. Clin Lab Med 2005; 25(1): 39-59.
11. Noone PG, Zhou Z, Silverman LM, Jowell PS, Knowles MR, Cohn JA. Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterology 2001; 121(6): 1310-9.
12. Schneider A. Serine protease inhibitor kazal type 1 mutations and pancreatitis. Clin Lab Med 2005; 25(1): 61-78.
13. Kim KP, Kim MH, Song MH, Lee SS, Seo DW, Lee SK. Autoimmune chronic pancreatitis. Am J Gastroenterol 2004; 99(8): 1605-16.
14. Sutton R. Autoimmune pancreatitis - also a Western disease. Gut 2005; 54(5): 581-3.
15. Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut 2002; 51(1): 1-4.
16. Ectors N, Maillet B, Aerts R, Geboes K, Donner A, Borchard F, et al. Non-alcoholic duct destructive chronic pancreatitis. Gut 1997; 41(2): 263-8.
17. Horiuchi A, Kawa S, Hamano H, Hayama M, Ota H, Kiyosawa K. ERCP features in 27 patients with autoimmune pancreatitis. Gastrointest Endosc 2002; 55(4): 494-9.
18. Kountouras J, Zavos C, Chatzopoulos D. A concept on the role of Helicobacter pylori infection in autoimmune pancreatitis. J Cell Mol Med 2005; 9(1): 196-207.
19. Kamisawa T, Egawa N, Inokuma S, Tsuruta K, Okamoto A, Kamata N, et al. Pancreatic endocrine and exocrine function and salivary gland function in autoimmune pancreatitis before and after steroid therapy. Pancreas 2003; 27(3): 235-8.
20. Uchida K, Okazaki K, Konishi Y, Ohana M, Takakuwa H, Hajiro K, et al. Clinical analysis of autoimmune-related pancreatitis. Am J Gastroenterol 2000; 95(10): 2788-94.
21. Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A, Kamata N. Clinical difficulties in the differentiation of autoimmune pancreatitis and pancreatic carcinoma. Am J Gastroenterol 2003; 99(12): 2694-9.
22. Procacci C, Carbognin G, Biasiutti C, Frulloni L, Bicego E, Spoto E, et al. Autoimmune pancreatitis: possibilities of CT characterization. Pancreatology 2001; 1(3): 246-53.
23. Van Hoe L, Gryspeerdt S, Ectors N, Van Steenbergen W, Aerts R, Baert AL, et al. Nonalcoholic duct-destructive chronic pancreatitis: imaging findings. Am J Roentgenol 1998, 170(3): 643-7.
24. Kawaguchi K, Koike M, Tsuruta K, Okamoto A, Tabata I, Fujita N. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol 1991; 22(4): 387-95.
25. Cavallini G. Is chronic pancreatitis a primary disease of the pancreatic ducts? A new pathogenetic hypothesis. Ital J Gastroenterol 1993; 25(7): 391-6.
26. Esposito I, Bergmann F, Penzel R, di Mola FF, Shrikhande S, Buchler MW, et al. Oligoclonal T-cell populations in an inflammatory pseudotumor of the pancreas possibly related to autoimmune pancreatitis: an immunohistochemical and molecular analysis. Virchows Arch 2004; 444(2): 119-26.
27. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001; 344(10): 732-8.
28. Aparisi L, Farre A, Gomez-Cambronero L, Martinez J, De Las Heras G, Corts J, et al. Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmnune pancreatitis. Gut 2005; 54(5): 703-9.
29. Okazaki K, Uchida K, Ohana M, Nakase H, Uose S, Inai M, et al. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 2000; 118(3): 573-81.
30. Ajjan RA, McIntosh RS, Waterman EA, Watson PF, Franklin CD, Yeoman CM, et al. Analysis of the T-cell receptor Valpha repertoire and cytokine gene expression in Sjogren's syndrome. Br J Rheumatol 1998; 37(2): 179-85.
31. Dienes HP, Lohse AW, Gerken G, Schirmacher P, Gallati H, Lohr HF, et al. Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis. Virchows Arch 1997; 431(2): 119-24.
32. Okazaki K. Autoimmune pancreatitis: etiology, pathogenesis, clinical findings and treatment. The Japanese experience. JOP 2005; 6 (1 Suppl): 89-96.
33. Kawa S, Ota M, Yoshizawa K, Horiuchi A, Hamano H, Ochi Y, et al. HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology 2002; 122(5): 1264-9.
34. Kojima E, Kimura K, Noda Y, Kobayashi G, Itoh K, Fujita N. Autoimmune pancreatitis and multiple bile duct strictures treated effectively with steroid. J Gastroenterol 2003; 38(6): 603-7.
35. Furukawa N, Muranaka T, Yasumori K, Matsubayashi R, Hayashida K, Arita Y. Autoimmune pancreatitis: radiologic findings in three histologically proven cases. J Comput Assist Tomogr 1998; 22(6): 880-3.
36. Song MH, Kim MH, Lee SK, Seo DW, Lee SS, Han J, et al. Regression of pancreatic fibrosis after steroid therapy in patients with autoimmune chronic pancreatitis. Pancreas 2005; 30(1): 83-6.
37. Ito T, Nakano I, Koyanagi S, Miyahara T, Migita Y, Ogoshi K, et al. Autoimmune pancreatitis as a new clinical entity. Three cases of autoimmune pancreatitis with effective steroid therapy. Dig Dis Sci 1997; 42(7): 1458-68.
38. Vallance BA, Hewlett BR, Snider DP, Collins SM. T cell-mediated exocrine pancreatic damage in major histocompatibility complex class II-deficient mice. Gastroenterology 1998, 115(4): 978-87.
39. Tsubata R, Tsubata T, Hiai H, Shinkura R, Matsumura R, Sumida T, et al. Autoimmune disease of exocrine organs in immunodeficient alymphoplasia mice: a spontaneous model for Sjogren's syndrome. Eur J Immunol 1996; 26(11): 2742-8.
40. Yamamichi M, Matsuoka N, Tomioka T, Eguchi K, Nagataki S, Kanematsu T. Shared TCR Vbeta gene expression by the pancreas and salivary gland in immunodeficient alymphoplasic mice. J Immunol 1997; 159: 427-32.
41. Kanno H, Nose M, Itoh J, Taniguchi Y, Kyogoku M. Spontaneous development of pancreatitis in the MRL/Mp strain of mice in autoimmune mechanism. Clin Exp Immunol 1992; 89(1): 68-73.
42. Hosaka N, Nose M, Kyogoku M, Nagata N, Miyashima S, Good RA, et al. Thymus transplantation, a critical factor for correction of autoimmune disease in aging MRL/+mice. Proc Natl Acad Sci USA 1996; 93(16): 8558-62.
43. Yamada T, Hashimoto T, Sogawa M, Kobayashi S, Kaneda K, Nakamura S, et al. Role of T cells in development of chronic pancreatitis in male Wistar Bonn/Kobori rats: effects of tacrolimus. Am J Physiol Gastrointest Liver Physiol 2001; 281(6): G1397-404.
44. Wiberg ME, Saari SA, Westermarck E, Meri S. Cellular and humoral immune responses in atrophic lymphocytic pancreatitis in German shepherd dogs and rough-coated collies. Vet Immunol Immunopathol 2000; 76(1-2): 103-15.
45. Hahm KB, Im YH, Lee C, Parks WT, Bang YJ, Green JE, et al. Loss of TGF-beta signaling contributes to autoimmune pancreatitis. J Clin Invest 2000; 105(8): 1057-65.
46. Yoo BM, Yeo M, Oh TY, Choi JH, Kim WW, Kim JH, et al. Amelioration of pancreatic fibrosis in mice with defective TGF-beta signaling. Pancreas 2005; 30(3): e71-9.
47. Jaster R. Molecular regulation of pancreatic stellate cell function. Mol Cancer 2004; 3(1): 26.
48. Uchida K, Okazaki K, Nishi T, Uose S, Nakase H, Ohana M, et al. Experimental immune-mediated pancreatitis in neonatally thymectomized mice immunized with carbonic anhydrase II and lactoferrin. Lab Invest 2002; 82(4): 411-24.
49. Sparmann G, Merkord J, Jaschke A, Nizze H, Jonas L, Lohr M, et al. Pancreatic fibrosis in experimental pancreatitis induced by dibutyltin dichloride. Gastroenterology 1997; 112(5): 1664-72.
50. Sparmann G, Behrend S, Merkord J, Kleine HD, Graser E, Ritter T, et al. Cytokine mRNA levels and lymphocyte infiltration in pancreatic tissue during experimental chronic pancreatitis induced by dibutyltin dichloride. Dig Dis Sci 2001; 46(8): 1647-56.
51. Wandschneider S, Fehring V, Jacobs-Emeis S, Thiesen HJ, Lohr M. Autoimmune pancreatic disease: preparation of pancreatic juice for proteome analysis. Electrophoresis 2001; 22(20): 4383-90.
52. Christopherson KW 2nd, Hromas RA. Endothelial chemokines in autoimmune disease. Curr Pharm Des 2004; 10(2): 145-54.
53. Eggert M, Kluter A, Zettl UK, Neeck G. Transcription factors in autoimmune diseases. Curr Pharm Des 2004; 10(23); 2787-96.
54. Pochet L, Frederick R, Masereel B. Coumarin and isocoumarin as serine protease inhibitors. Curr Pharm Des 2004; 10(30): 3781-96.